Engene Therapeutics Inc.
Filed as ENGENE THERAPEUTICS INC (COM), Equity As of 2026 Q2 among managers we track
- 1 Owner
- Max 0.0%
- $129K
- 1 new
In 2026 Q2 Nathan Fischel opened a position in Engene Therapeutics.
Who owns this now
Largest portfolio weights among holders, up to 0.0% (Nathan Fischel, Dafna Capital Management). Not free-float ownership.
Holders
Sorted by value, long equity only, as of 2026 Q2.
| History | |||||
|---|---|---|---|---|---|
| Nathan Fischel, Dafna Capital Management | New 0.02% | 74,650 | $129K | History |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.